Intellectual Property India Publishes Patent Application for 'Sustained Release Matrix Tablet Formulation Of Nebivolol Hydrochloride Using A Dual-Polymer Matrix And Method Of Preparation Thereof' Filed by Dr. Divya Ajmeera; Dr. Shanthipriya Ajmera; Prof. Sarangapani Manda; and Dr. Rajanna Ajumeera

MUMBAI, India, April 17 -- Intellectual Property India has published a patent application (202641043562 A) filed by Dr. Divya Ajmeera; Dr. Shanthipriya Ajmera; Prof. Sarangapani Manda; and Dr. Rajanna Ajumeera, Karimnagar, Telangana, on April 6, for 'sustained release matrix tablet formulation of nebivolol hydrochloride using a dual-polymer matrix and method of preparation thereof.'

Inventor(s) include Dr. Divya Ajmeera; Dr. Shanthipriya Ajmera; Prof. Sarangapani Manda; and Dr. Rajanna Ajumeera.

The application for the patent was published on April 17, under issue no. 16/2026.

According to the abstract released by the Intellectual Property India: "The present invention relates to a sustained release oral matrix tablet formulation of Nebi...